OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia
Yuxin Tan, Lilan Xin, Qian Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216933-216933
Closed Access | Times Cited: 5
Yuxin Tan, Lilan Xin, Qian Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216933-216933
Closed Access | Times Cited: 5
Showing 5 citing articles:
Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML
Petra Bašová, Lubomír Minařík, Silvia Magalhaes Novais, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Petra Bašová, Lubomír Minařík, Silvia Magalhaes Novais, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
The Peptide PROTAC Modality: A New Strategy for Drug Discovery
Youmin Zhu, Yu Dai, Yun-Cai Tian
MedComm (2025) Vol. 6, Iss. 4
Open Access
Youmin Zhu, Yu Dai, Yun-Cai Tian
MedComm (2025) Vol. 6, Iss. 4
Open Access
Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AML
Mingfei Wu, Wei Wang, Xinfei Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116539-116539
Closed Access | Times Cited: 3
Mingfei Wu, Wei Wang, Xinfei Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116539-116539
Closed Access | Times Cited: 3
Identification of inhibitors targeting the FLT3-ITD mutation through 4D-QSAR, in vitro, and in silico
Dongchen Chu, Cuicui Ji, Liang Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117089-117089
Closed Access | Times Cited: 1
Dongchen Chu, Cuicui Ji, Liang Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117089-117089
Closed Access | Times Cited: 1
Overcoming Resistance to FLT3-ITD Therapeutics
Campbell McInnes
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Campbell McInnes
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access
